Chronic Obstructive Pulmonary Disease

Early Diagnosis, Screening and Biomarkers

Early diagnosis is critical for slowing disease progression and improving long-term outcomes. This track examines advances in screening programs, pulmonary function testing, spirometry, imaging technologies, and laboratory biomarkers used for early COPD detection. Discussions include risk assessment, disease classification, precision diagnostics, artificial intelligence-assisted screening, and novel diagnostic tools that support accurate and timely clinical decision-making. Emerging biomarkers also offer promising opportunities for monitoring disease activity and predicting treatment response.